Cisplatin

ERCC excision repair 1, endonuclease non-catalytic subunit ; Homo sapiens







287 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
201 17905465 ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer. 2008 Mar 4
202 17953711 Clinical relevance of the homologous recombination machinery in cancer therapy. 2008 Feb 2
203 18231104 Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. 2008 Feb 26 1
204 18347182 Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. 2008 Mar 15 2
205 18402708 ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel. 2008 Apr 11 6
206 18425336 ERCC1 codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy. 2008 May 1
207 18483312 Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1. 2008 May 1
208 18594541 ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. 2008 Jul 8 3
209 18623378 ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy. 2008 Sep 15 2
210 18640939 Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer. 2008 Jul 20 1
211 18645262 Upregulation of ZNRD1 enhances cisplatin resistance in human esophageal cancer cells by regulation of ERCC1 and Bcl-2. 2008 1
212 18756932 [Relationship between nucleotide excision repair gene ERCC1 and resistance to cisplatin in ovarian cancer]. 2008 Mar 10
213 18827563 Activity of lipoplatin in tumor and in normal cells in vitro. 2008 Nov 1
214 19080461 [RNA interference silencing excision repair cross-complementing 1 gene and affecting cisplatin sensitivity on lung cancer cell lines]. 2008 Oct 28 3
215 19578506 Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer. 2008 Apr 17 4
216 21885003 Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer. 2008 Mar 1
217 17151930 Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma. 2007 May 3
218 17229776 Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy. 2007 Mar 1
219 17489733 Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy response. 2007 May 1
220 17534174 ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer. 2007 Jul 3
221 17600754 Nuclear excision repair-based personalized therapy for non-small cell lung cancer: from hypothesis to reality. 2007 1
222 17602080 Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer. 2007 Jul 1 5
223 17606717 Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma. 2007 Jul 1 4
224 17607914 Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract. 2007 1
225 17686445 How could pharmacogenomics help improve patient survival? 2007 Aug 1
226 18157593 [Biomarkers - the way towards individualized chemotherapy in non-small cell lung cancer (NSCLC)]. 2007 2
227 18235415 [Predicting the response to chemotherapy in patients with non-small cell lung cancer]. 2007 Oct 1
228 19190690 ERCC1 Expression in Diffuse Large B-Cell Lymphoma Patients Treated with a Cisplatin-Based Regimen : A Brief Communication. 2007 Sep 4
229 21126401 [Relationship between ERCC1 expression and cisplatin intervention in human lung adenocarcinoma cell lines]. 2007 Oct 20 15
230 16426580 MZF1 possesses a repressively regulatory function in ERCC1 expression. 2006 Mar 14 4
231 16462182 Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going. 2006 Mar 1
232 16632419 From the bench to the bed: individualizing treatment in non-small-cell lung cancer. 2006 Feb 1
233 16690105 Determination of the mechanism of gemcitabine modulation of cisplatin drug resistance in panel of human endometrial cancer cell lines. 2006 Nov 2
234 16756962 XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair. 2006 Jul 14 4
235 16762192 [Enhanced cisplatin cytotoxicity by RNA interfering the excision repair cross-complementing 1 gene in ovarian cancer cell lines]. 2006 May 3
236 16765644 Predicting the outcome of chemotherapy for lung cancer. 2006 Aug 1
237 16935774 Usefulness of predictive tests for cancer treatment. 2006 Aug 1
238 16957145 DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. 2006 Sep 7 3
239 16980606 ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. 2006 Dec 4
240 17163161 Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract. 2006 1
241 17303907 Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients. 2006 2
242 19771254 Increased ERCC expression correlates with improved outcome of patients treated with cisplatin as an adjuvant therapy for curatively resected gastric cancer. 2006 Feb 7
243 15629453 Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin. 2005 Feb 4 9
244 15688021 Expression of a splicing variant in the 5'-UTR of the human ERCC1 gene is not cancer related. 2005 Mar 17 3
245 16551521 Applications of genomics in NSCLC. 2005 Dec 2
246 16557672 Applications of genomics in NSCLC. 2005 Dec 2
247 14706347 Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells. 2004 Feb 3 4
248 14977831 Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. 2004 Feb 15 2
249 14981577 Molecular predictors of response to chemotherapy in lung cancer. 2004 Feb 2
250 15140544 Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. 2004 Jun 2